RA PHARMACEUTICALS
Ra Pharma is developing Cyclomimetics, a new drug class with the diversity and specificity of antibodies, coupled with the many benefits of small molecules. Ra Pharma is leveraging its ability to rapidly generate drug candidates to develop its own portfolio of products and partnerships focused on intracellular protein-protein interactions and other innovative approaches to addressing unmet medical needs. It was founded in 2008 and headquartered in Cambridge, Massachusetts.
RA PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.rapharma.com
Total Employee:
5001+
Status:
Active
Contact:
617-401-4060
Email Addresses:
[email protected]
Total Funding:
226.93 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Microsoft Microsoft Azure New Relic Mobile Optimized
Similar Organizations
Actinium Pharmaceuticals
Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Synta Pharmaceuticals
Synta Pharmaceuticals is focused on developing and commercializing small molecule drugs to treat cancer and chronic inflammatory diseases.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Founder
Stock Details
Investors List
Rock Springs Capital
Rock Springs Capital investment in Series B - Ra Pharmaceuticals
Morgenthaler Ventures
Morgenthaler Ventures investment in Series B - Ra Pharmaceuticals
Amgen Ventures
Amgen Ventures investment in Series B - Ra Pharmaceuticals
Novo Ventures
Novo Ventures investment in Series B - Ra Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series B - Ra Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series B - Ra Pharmaceuticals
Limulus Venture Partners
Limulus Venture Partners investment in Series B - Ra Pharmaceuticals
Lightstone Ventures
Lightstone Ventures investment in Series B - Ra Pharmaceuticals
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Ra Pharmaceuticals
Official Site Inspections
http://www.rapharma.com Semrush global rank: 1.4 M Semrush visits lastest month: 20.35 K
- Host name: 51.144.52.30
- IP address: 51.144.52.30
- Location: Amsterdam Netherlands
- Latitude: 52.3534
- Longitude: 4.9087
- Timezone: Europe/Amsterdam
- Postal: 1091
More informations about "Ra Pharmaceuticals"
Ra Pharmaceuticals Company Profile - Office Locations ... - Craft
Jul 23, 2018 · Ra Pharmaceuticals $3 m in annual revenue in FY 2019. See insights on Ra Pharmaceuticals including office locations, competitors, revenue, financials, executives, …See details»
Ra Pharmaceuticals - Crunchbase Company Profile
Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules. View contacts for Ra Pharmaceuticals to access new leads and connect with decision-makers.See details»
Ra Pharmaceuticals Company Profile 2024: Valuation, …
Ra Pharmaceuticals was founded in 2008. Where is Ra Pharmaceuticals headquartered? Ra Pharmaceuticals is headquartered in Cambridge, MA. What is the size of Ra Pharmaceuticals? Ra Pharmaceuticals has 89 total employees. …See details»
UCB completes the acquisition of Ra Pharmaceuticals – to deliver ...
Apr 2, 2020 · Ra Pharma, now a wholly-owned subsidiary of UCB, is a clinical-stage biopharmaceutical company leveraging a proprietary peptide chemistry platform to develop …See details»
Ra Pharmaceuticals Inc - Company Profile and News
Ra Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company offers drugs for the treatment of cancer, inflammation and autoimmune disease, diabetes, and...See details»
UCB agrees to acquire Ra Pharmaceuticals: Joining forces to …
Oct 10, 2019 · Ra Pharma is a clinical-stage biopharmaceutical company leveraging a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases …See details»
RaPharma - VentureRadar
"Ra Pharma is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare …See details»
UCB Completes the Acquisition of Ra Pharmaceuticals
BRUSSELS, April 2, 2020 /PRNewswire/ -- UCB today announced that the acquisition of Ra Pharmaceuticals, Inc. has been successfully completed and Ra Pharma is now a wholly-owned subsidiary of UCB....See details»
UCB sets sights on rare diseases giant Alexion with Ra Pharma ...
Oct 10, 2019 · UCB is to buy US biotech Ra Pharma in a deal worth around $2.1 billion, adding a late-stage treatment for the rare muscle weakness disease myasthenia gravis to its R&D …See details»
UCB acquires Ra Pharma for $2.1bn to enrich its rare …
Oct 11, 2019 · UCB has acquired Massachusetts-based Ra Pharmaceuticals for $48 per share, bringing the total transaction to a value of approximately $2.1bn. This deal is in line with UCB’s 2019 strategic growth path, and would bring Ra …See details»
UCB to acquire Ra Pharmaceuticals in $2.1bn deal
Belgian biopharmaceutical firm UCB has signed a merger agreement to acquire US-based Ra Pharmaceuticals for $48 per share, totalling $2.1bn in cash. Ra Pharma is developing treatments for serious diseases driven by abnormal …See details»
UCB Cuts $2.1 Billion Deal to Acquire Ra Pharma - the-scientist.com
Oct 14, 2019 · Brussels-based drugmaker UCB has agreed to acquire Massachusetts-based Ra Pharma for $2.1 billion, according to a joint statement published last week (October 10).See details»
UCB to Acquire Ra Pharma for $2.1B, Raising Rare Disease Presence
Oct 10, 2019 · Ra Pharma is recruiting patients for the Phase III RAISE trial ( NCT04115293 ), a multicenter, randomized, double-blind, placebo-controlled study designed to confirm the …See details»
UCB Acquires Ra Pharma, Adds Zilucoplan to Its MG Pipeline
Apr 21, 2020 · UCB has completed its acquisition of Ra Pharmaceuticals, priced at about $2.3 billion, meaning that zilucoplan — an investigational treatment for myasthenia gravis (MG) — …See details»
Ra Pharmaceuticals Earns Clinical Development Milestone for Oral ...
Aug 21, 2019 · Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients …See details»
UCB agrees to acquire Ra Pharmaceuticals: Joining forces to …
Ra Pharma is a clinical-stage biopharmaceutical company leveraging a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases caused …See details»
RaPharma | VentureRadar
Website: http://www.rapharma.com/ Ra Pharma is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible …See details»
UCB Agrees to Acquire Ra Pharmaceuticals: Joining ... - Business …
Oct 10, 2019 · Ra Pharma is a clinical-stage biopharmaceutical company leveraging a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases …See details»
Ra Pharmaceuticals Earns Clinical Development Milestone for Oral ...
Aug 21, 2019 · Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients …See details»